STERIS’ (TSE:STE – Free Report) – Investment analysts at Raymond James reduced their FY2025 EPS estimates for shares of STERIS’ in a research report issued to clients and investors on Wednesday, March 12th. Raymond James analyst M. Barth now anticipates that the company will post earnings of $0.64 per share for the year, down from their prior forecast of $0.76. Raymond James also issued estimates for STERIS’’s FY2029 earnings at $0.68 EPS.
A number of other brokerages also recently issued reports on STE. Cormark raised shares of STERIS’ to a “moderate buy” rating in a research report on Monday, January 6th. Atb Cap Markets raised shares of STERIS’ to a “strong-buy” rating in a research report on Sunday, December 22nd.
STERIS’ Stock Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
See Also
- Five stocks we like better than STERIS’
- How to Find Undervalued Stocks
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- How to buy stock: A step-by-step guide for beginners
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Energy and Oil Stocks Explained
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
